Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.

@article{Bauernfeind1982ElectrophysiologicDT,
  title={Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.},
  author={Rosi Bauernfeind and Steven Swiryn and Boris Strasberg and E A Palileo and Daniel Scagliotti and K. M. Rosen},
  journal={American heart journal},
  year={1982},
  volume={103 6},
  pages={941-9}
}
Electrophysiologic drug testing was performed in nine patients with severely symptomatic sporadic (2 to 13 [mean 4.2] attacks/24 months) paroxysmal atrial fibrillation (PAF). All patients had control inductions of sustained (greater than 30 seconds) AF by high right atrial stimulation, and attempted inductions following serial administration of drugs. Drugs tested were intravenous procainamide (1.0 to 1.5 gm) (five patients), intravenous propranolol (0.1 mg/kg) (three patients), oral quinidine… CONTINUE READING